Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: Results of a double blind multicentre clinical trial-Reference-Cited by-同舟云学术

Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: Results of a double blind multicentre clinical trial

Published:1988-12 Issue:12 Volume:24 Page:1851-1853
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Bonneterre J.,Mauriac L.,Weber B.,Roche H.,Fargeot P.,Tubiana-Hulin M.,Sevin M.,Chollet P.,Cappelaere P.

Publisher

Elsevier BV

Subject

Oncology

Reference9 articles.

1. Prolactin receptors in human breast cancer;Bonneterre;Eur J Cancer Clin Oncol,1982

2. Stimulation of DNA synthesis by prolactin in human breast tumor explants;Peyrat,1984

3. Clinical trial of 2-Br-ergocriptine (CB154) in advanced breast cancer;Eur J Cancer,1972

4. Combined antiprolactin and anti-estrogen therapy for breast cancer;Ward;Clin Oncol,1977

5. High dose medroxyprogesterone acetate (HD-MPA) vs. HD-MPA + bromocriptine (BR) in metastatic breast cancer; a randomized multicentric clinical trial;Robustelli Della Cuna,1986

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer;Journal of Experimental & Clinical Cancer Research;2024-06-20

2. Connections between prolactin and ovarian cancer;PLOS ONE;2021-08-06

3. Human Cytomegalovirus Infection Induces High Expression of Prolactin and Prolactin Receptors in Ovarian Cancer;Biology;2020-02-27

4. ATM Is Required for the Prolactin-Induced HSP90-Mediated Increase in Cellular Viability and Clonogenic Growth After DNA Damage;Endocrinology;2017-11-24

5. A pilot study of cabergoline for the treatment of metastatic breast cancer;Breast Cancer Research and Treatment;2017-07-03